The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Lets hope it delivers the three 'Boomer' RNS we are all waiting for:
Results
Covid Update (Positive)
One other from its string of work
Maybe a fourth is a little wishful thinking but in Vlad we trust, one more day to go before results.
The funding of the placement allowed the production to happen back in April but to scale that up would require a big Pharma or Institutional investors with clout to fund up scaling.
I guess they have a number of options:
1) Slow supply until the have money in the bank to do themselves (not likely)
2) Institutional Money to Upscale Supply
3) Big Pharma License agreement
4) Takeover and let someone else worry about the supply chain
I'm not sure they would want 1 or 2 themselves as that's not there area of expertise, so i'm hoping for 4.
A quick comment from me and agree that we have quite a few fronts the team at HEMO are working on.
Yesterday, a couple of vaccine trials we're paused and the scientific folk on the news reflected this as a good thing. Which when you listen to the explanation, it put it into prospective and that its part of the Phase's.
That said, im sure we will have some bumps on the road for Hemo but we should remember that it is to be expected.
I have been in since March/April, its been a bumpy ride but I am totally convinced that HEMO will present some amazing solutions and make a lot of us money along the way.
GLA
PS: nice to see the muppets gone for now
So basically 8 Phase III trials for vaccines and expect paused effect due to side effects.
No real vaccine until next year
Treatments - Steroids was the only mention of success but Hydrox......& HIV Drugs have no effect
Deximethodome (steriod) mentioned as a success. Then finished talking and didnt mention any treatments at any phase.
ignore my spelling of drugs
Watching the interview they are well set for winter.
Sng0001 works with steriods and they set the manufacturing cycle back in April.
To me its a bid by government for first batch and a Big Pharma to buyout or huge License Payment.
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/0abf7a95-174b-3aa6-9568-cf16e5b613ee
Synairgen trial shows drug-enhancing lung response in some patients
Anna Gross in London
The immunosuppressant drug interferon beta enhanced the lung response of patients with Chronic Obstructive Pulmonary Disease (COPD), biotech company Synairgen said on Tuesday.
Patients whose conditions were acutely deteriorating and were given interferon beta, which is commonly used to treat multiple sclerosis and thyroid dysfunction, had “significantly better lung function during the treatment period”, interim results from the company's study involving 109 COPD patients showed.
Shares in Synairgen, which spun out from Southampton University, rose 9 per cent to 214 pence in early morning trading on Tuesday. The group's stock may have waned a touch recently, rising 1.5 per cent for the month to date. However, for the year the group's stock has risen 3,355 per cent, Refinitiv data show for early trading on Tuesday.
The group unveiled trial results in July that showed interferon beta increased the likelihood of recovery among patients hospitalised with Covid-19.
In a study involving 101 patients from nine UK hospitals, those who were given the immunosuppressant drug were more than twice as likely to recover and were 79 per cent less likely to develop a more severe version of the disease.
Their breathlessness was also “markedly reduced”, the company said.
We are back to the waiting game and the hype of the expected RNS has seen the profit/day traders jump in and out. It wont be long as investors in HEMO know, we are expecting news on many fronts.
The RNS will drop out of the blue as Vlad likes to keep us all guessing and then HEMO will move into the space where everyone wants a piece.
GLA
All the fun on dips, the MM’s and Profit Takers/stop losses being taken and the MM’s want your shares for a reason.
MM’s know this will make them some money and are on this share because of that. Dips/Shakes are to be expected but are forgotten once news lands.
SNG went from 70 to 35p and then 2.50 to 1.80 so its just a day of patience and nerves
This is going to multi bag very quickly and news is imminent in my opinion and when that positive RNS lands, who knows where the SP will rise to, its such an opportunity, people will be be locked out until £1.
Newbies saying it will fall, you maybe right but i also think you are missing the research. More likely shakes to scare the 10% profit takers but after that. It will be just wow
Quite a lot have been here for sometime and waiting patiently for the rise and news.
Lets not forget the Eli news is due soon
Covid is due
Plus other news that Vlad is working on and we all new our day was coming and with that the herd and new investors.
The herd have arrived and i wish you all well with whatever strategy you have. Lets not ruffle the old guard and have this board as a contest.
GLA